Total Payments
$2,369
2024 Payments
$137.01
Companies
22
Transactions
110
Medicare Patients
232
Medicare Billing
$23,666
Payment Breakdown by Category
Food & Beverage$2,369 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,369 | 110 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $444.47 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $279.69 | 10 | $0 (2021) |
| Novo Nordisk Inc | $245.25 | 18 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $217.55 | 10 | $0 (2021) |
| Eisai Inc. | $145.89 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $145.47 | 8 | $0 (2021) |
| Amarin Pharma Inc. | $119.47 | 7 | $0 (2021) |
| Gilead Sciences, Inc. | $108.39 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $103.26 | 6 | $0 (2021) |
| PFIZER INC. | $90.07 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137.01 | 1 | ABBVIE INC. ($137.01) |
| 2023 | $214.29 | 2 | Gilead Sciences, Inc. ($108.39) |
| 2022 | $141.80 | 4 | Biogen, Inc. ($81.97) |
| 2021 | $1,875 | 103 | GlaxoSmithKline, LLC. ($279.69) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $137.01 | General |
| 11/16/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $108.39 | General |
| Category: HCV | ||||||
| 01/19/2023 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $105.90 | General |
| 06/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $81.97 | General |
| 02/02/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Diabetes | ||||||
| 12/09/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $118.74 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2021 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Gastroenterology | ||||||
| 08/19/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: Neurology | ||||||
| 08/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/11/2021 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: VACCINES | ||||||
| 07/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Diabetes | ||||||
| 07/12/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: Diabetes | ||||||
| 07/09/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 141 | 150 | $60,833 | $14,574 |
| 2022 | 4 | 91 | 92 | $34,592 | $9,092 |
Total Patients
232
Total Services
242
Medicare Billing
$23,666
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $26,592 | $6,124 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 39 | $14,196 | $3,894 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $13,870 | $2,902 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 25 | $6,175 | $1,653 | 26.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $13,806 | $3,459 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $11,298 | $2,837 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 16 | $5,648 | $1,681 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $3,840 | $1,115 | 29.0% |
About Elena Beider, PA-C
Elena Beider, PA-C is a Medical healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013016724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elena Beider, PA-C has received a total of $2,369 in payments from pharmaceutical and medical device companies, with $137.01 received in 2024. These payments were reported across 110 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,369).
As a Medicare-enrolled provider, Beider has provided services to 232 Medicare beneficiaries, totaling 242 services with total Medicare billing of $23,666. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Daly City, CA
- Active Since 09/21/2006
- Last Updated 01/05/2022
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1013016724
Products in Payments
- XARELTO (Drug) $217.55
- Ozempic (Drug) $215.53
- UBRELVY (Drug) $175.39
- Vascepa (Drug) $119.47
- ZEJULA (Drug) $118.74
- Epclusa (Drug) $108.39
- TRELEGY ELLIPTA (Drug) $107.92
- XIFAXAN (Drug) $85.80
- VRAYLAR (Drug) $76.36
- SYNJARDY (Drug) $71.45
- FARXIGA (Drug) $64.27
- JARDIANCE (Drug) $57.16
- PREVNAR 13 (Biological) $51.87
- VIBERZI (Drug) $47.79
- ENTRESTO (Drug) $45.54
- BREZTRI (Drug) $42.62
- ANORO ELLIPTA (Drug) $40.64
- Dayvigo (Drug) $39.99
- FASENRA (Biological) $38.58
- Otezla (Drug) $30.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.